Logos Global Management
PRDS

Logos Global Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Logos Global Management’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-123,543
Closed -$1.23M – 71
2021
Q2 		$1.23M Sell
123,543
-176,457
-59% -$1.77M 0.1% 52
2021
Q1 		$2.99M Buy
+300,000
New +$3.1M 0.29% 43

Other funds holding PRDS

Arena Capital Advisors
Arena Capital Advisors Los Angeles, California $200M AUM 6.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
JCM
JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return
PFM Health Sciences
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Platinum Investment Management
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Sage Rock Capital Management
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
Foresite Capital Management V
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return

Logos Global Management's PRDS Position: Q3 2021 in Review

Logos Global Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2021, closing a stake of 123,543 shares — an estimated $1.23M sold.

Logos Global Management first reported a position in PRDS in Q1 2021 and held it in 2 quarters. The position peaked at $2.99M in Q1 2021. 61 funds tracked by Wall St. Rank hold PRDS as of Q3 2021.

  • Logos Global Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Logos Global Management sold 123,543 Pardes Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $1.23M.
  • Logos Global Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Logos Global Management's Pardes Biosciences, Inc. Common Stock position peaked at $2.99M in Q1 2021.
  • 61 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2021.

Based on Logos Global Management's 13F filing for Q3 2021, filed 15 Nov 2021.